Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma

We have recently reported tumor suppressive role of DAB2IP in RCC development. In this study, We identified one CpG methylation biomarker (DAB2IP CpG1) located UTSS of DAB2IP that was associated with poor overall survival in a cohort of 318 ccRCC patients from the Cancer Genome Atlas (TCGA). We furt...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zong-Ren, Wei, Jin-Huan, Zhou, Jian-Cheng, Haddad, Ahmed, Zhao, Liang-Yun, Kapur, Payal, Wu, Kai-Jie, Wang, Bin, Yu, Yan-Hong, Liao, Bing, He, Da-Lin, Chen, Wei, Margulis, Vitaly, Hsieh, Jer-Tsong, Luo, Jun-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058774/
https://www.ncbi.nlm.nih.gov/pubmed/27129174
http://dx.doi.org/10.18632/oncotarget.8971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058774/
https://www.ncbi.nlm.nih.gov/pubmed/27129174
http://dx.doi.org/10.18632/oncotarget.8971

Ejemplares similares